Programme of the conference

19 SeptemberFriday
  • 11:00-11:30 — Welcome brunch
  • 11:30-11:40 — Opening ceremony
  • Welcome (10 min)

    Marta Sobas and Wojciech Świstek. Department of Hematology. Collegium Medicum, Medical University of Bydgoszcz, Poland.

  • 11:40-13:20 — Therapy of acute myeloblastic leukemia

    Chairs: Agnieszka Wierzbowska, Maria Podolak-Dawidziak, Pau Montesinos, Lidia Gil

  • Breaking Bad: AML edition (20 min)

    Agnieszka Wierzbowska, Medical University of Łódź, Poland.

  • No Time to …..Bleeding: Hemostatic Disorders in Leukemias (20 min)

    Maria Podolak-Dawidziak, Wroclaw Medical University, Poland.

  • Miracle on APL Street (20 min)

    Pau Montesinos, Hospital La Fe, Valencia, Spain.

  • Past, Present, Future. Cell therapy in AML (20 min)

    Lidia Gil, Medical University of Poznań, Poland.

  • Discussion (20 min)
  • 13:20 – 14:20 — LUNCH
  • 14:20 – 15:40 — How can be AML outcome improved?

    Chairs: Michael Dennis, Artur Kowalik, Amin Turky

  • Genome of Secrets. Uncovering the blastic crisis of MPN and MDS (20 min)

    Artur Kowalik, Division of Medical Biology, Jan Kochanowski University, Kielce, Poland.

  • Trainspotting – the utility of MRD for treatment decision making in AML (20 min)

    Michael Dennis, The Christie NHS Foundation Trust, Manchester, United Kingdom.

  • The Matrix of Leukemia: When AI sees the Truth. International testing and refinement of an AI algorithm to predict acute leukemia - subtypes from routine laboratory data (20 min)

    Amin Turky, Essen, Germany, HARMONY.

  • Discussion (20 min)
  • 15:40 – 16:00 — COFFEE BREAK
  • 16:00 – 17:40 — Chronic myeloid leukemia

    Chairs: Tomasz Sacha, Joanna Góra-Tybor, Sebastian Szmit, Laura Li Gagnon

  • Chronic myelocytic leukemia: Mission Possible – Evolving Goals and Strategies for CML Therapy (20 min)

    Tomasz Sacha, Jagiellonian University, Krakow, Poland.

  • The blastic phase of CML rises – How to treat refractory/resistant and blastic phase of CML? (20 min)

    Joanna Góra-Tybor, Medical University of Łódź, Poland.

  • Doctor Heart: a cardiology story in CML (20 min)

    Sebastian Szmit, Head, Department of Cardio-Oncology CMKP, Warsaw, Poland.

  • MPN with concomitant CML: Dawn of Coexistance (20 min)

    Laura Li Gagnon, Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.

  • Discussion (20 min)
  • 17:40 – 18:00 — COFFEE BREAK
  • 18:00 – 19:20 — From bench to patient

    Chairs: Claire Harrison, Marta Sobas, Pau Montesinos, Agnieszka Wierzbowska

  • The English (NHS) Patient...... and nurses. The Nurses role in the management of MPN patients (20 min)

    Claire Woodley, Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.

  • Interactive clinical case studies – part 1
    • Case 1
    • Case 2
    • Case 3
    • Case 4
  • 20:00 — DINNER (Still to be announced)
20 SeptemberSaturday
  • 08:00 – 10:00 — MDS and MPN: blastic transformation

    Chairs: Krzysztof Mądry, Claire Harrison, Tata Nageswara Rao, Krzysztof Lewandowski, Patryk Sobieralski

  • Shakespeare in hematology: MDS or AML, that’s the question (20 min)

    Krzysztof Mądry, Warsaw Medical University, Poland.

  • Inception. Are we able to modify the disease? Can we prevent MPN progression? (20 min)

    Claire Harrison, Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, United Kingdom.

  • The eroded stem cell garden of myelofibrosis – novel diagnostic pathfinders and therapeutic uprooters (20 min)

    Tata Nageswara Rao, Department of Oncology and Hematology, Medical Research Center, Cantonal Hospital St. Gallen, Switzerland; Institute for Pharmacology, University of Bern, Bern, Switzerland.

  • Chronicle of a Death Foretold – blastic phase of MPN (20 min)

    Krzysztof Lewandowski, Medical University of Poznań, Poland.

  • Doubt. Transplant or not to transplant blastic phases of MPN? (20 min)

    Patryk Sobieralski, Medical University of Gdańsk, Poland.

  • Discussion (20 min)
  • 10:00 – 10:20 — COFFEE BREAK
  • 10:20 – 10:40 — Acute lymphoblastic leukemia

    Chairs: Adele Fielding, Sebastian Giebel, Jan Styczyński

  • Hope gap. ALL: is chemotherapy-free treatment a realistic proposition? (20 min)

    Adele Fielding, Hull York Medical School, University of York, United Kingdom.

  • CAR-T and ALL: Avengers Endgame? (20 min)

    Sebastian Giebel, Maria Sklodowska-Curie National Oncology Institute, Gliwice, Poland.

  • Bruce AL(L)mighty: Fighting Pediatric and Adolescence Leukemia (20 min)

    Jan Styczyński, Department of Pediatric Hematology and Oncology. Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń.

  • Discussion (20 min)
  • 11:40 – 13:00 — “Problematic” leukemias

    Chairs: Marta Sobas, Irene Navarro Vicente, Guy Pratt

  • Double lif(n)e of MPAL (20 min)

    Marta Sobas, Collegium Medicum, Medical University of Bydgoszcz, Poland.

  • The curious case of blastic dendritic cell neoplasms (20 min)

    Irene Navarro Vicente, Hospital La Fe, Valencia, Spain.

  • Alien: Plasma cell leukemia (20 min)

    Guy Pratt, Cancer Research UK Clinical Trials Unit, University of Birmingham, United Kingdom.

  • Discussion (20 min)
  • 13:00 – 14:00 — LUNCH
  • 14:00 – 16:40 — Chronic lymphocytic leukemia

    Chairs: David Allsup, Krzysztof Jamroziak, Krzysztof Giannopoulos, Tomasz Wróbel

  • Mission (im)possible. Are We Close to a Cure for Chronic Lymphocytic Leukemia? (20 min)

    David Allsup, Hull York Medical School, University of Hull, United Kingdom.

  • Empire Strikes Back? How to treat double-refractory CLL and Richter syndrome (20 min)

    Krzysztof Jamroziak, Department of Hematology, Transplantation and Internal Medicine, Warsaw Medical University, Poland.

  • The outfit – Tailoring Treatment: How the presence of Unmutated IGHV and/or TP53 Mutations Change the Approach to Chronic Lymphocytic Leukemia? (20 min)

    Krzysztof Giannopoulos, Department of Experimental Hematooncology, Medical University of Lublin, Poland.

  • Edge of tomorrow? Investigating the potential of CAR T-cells and bispecific antibodies in CLL (20 min)

    Tomasz Wróbel, Wroclaw Medical University, Poland.

  • Discussion (20 min)
  • 16:40 – 17:00 — COFFEE BREAK
  • 17:00 – 18:00 — From bench to patient

    Chairs: to be announced

  • Interactive clinical case studies – part 2
    • Case 1
    • Case 2
    • Case 3
    • Case 4
  • 17:40 – 18:00 — Closing ceremony

    Marta Sobas and Wojciech Świstek

  • 19:00 — DINNER (City Hotel restaurant)
21 SeptemberSunday
  • #MedUpdate 2025 BYDGOSZCZ – 21.09.2025

    As part of the international conference “The Secret Garden of Leukemias”

  • During the conference, there will be a box available for patients’ questions/comments

    Agenda

Logistical Organizer

The logistical organizer of the conference is the company JMJ Sp. z o.o.

Details:
JMJ Sp. z o.o.
6/49 Bachmacka Street
02-647 Warsaw
VAT ID: 554 21 98 780

Contact:
Jowita Bąk
e-mail: jowita.bak@jmjbiznes.pl
phone: +48 501 032 095